澳大利亚确保药品支助交易,以改善农村护理并抵消Vyvanse价格削减费用。 Australia secures pharmacy support deal to improve rural care and offsets Vyvanse price cut costs.

澳大利亚政府与澳大利亚制药协会达成了一项协议,通过《第一药房方案协定》,支持药品审查和药剂师处方,维持农村和偏远地区的药房服务。 The Australian government has secured a Heads of Agreement with the Pharmaceutical Society of Australia to sustain rural and remote pharmacy services through the First Pharmacy Programs Agreement, supporting medicine reviews and pharmacist prescribing. 该协议加强了包括土著和托雷斯海峡岛民社区在内的服务不足地区获得护理的机会,并与国家卫生目标保持一致。 The deal reinforces access to care in underserved areas, including Aboriginal and Torres Strait Islander communities, and aligns with national health goals. 与此同时,Takeda和药剂协会商定了一项退款,以帮助药店抵消2025年12月对Vyvanse的PBS价格削减造成的财政损失,解决与存货有关的费用问题。 Meanwhile, Takeda and the Pharmacy Guild agreed on a rebate to help pharmacies offset financial losses from a December 2025 PBS price cut for Vyvanse, addressing concerns over stock-related costs.